Pharma & Healthcare
Global Opioid Drugs Market Research Report 2024
- Jan 29, 24
- ID: 49804
- Pages: 72
- Figures: 143
- Views: 19
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global Opioid Drugs market was valued at US$ 10050 million in 2023 and is anticipated to reach US$ 14730 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Opioid Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Drugs.
Report Scope
The Opioid Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioid Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acura Pharmaceuticals
Cipher Pharmaceutical Inc.
Daiichi Sankyo
Johnson&Johnson
Lupin Limited
Pfizer
Sun Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Segment by Type
Buprenorphine
Fentanyl
Hydrocodone
Morphine
Oxycodone
Tramadol
Others
Segment by Application
Anesthesia
Pain relief
Cough suppression
Diarrhea suppression
Deaddiction
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Opioid Drugs market was valued at US$ 10050 million in 2023 and is anticipated to reach US$ 14730 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Opioid Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Drugs.
Report Scope
The Opioid Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioid Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acura Pharmaceuticals
Cipher Pharmaceutical Inc.
Daiichi Sankyo
Johnson&Johnson
Lupin Limited
Pfizer
Sun Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Segment by Type
Buprenorphine
Fentanyl
Hydrocodone
Morphine
Oxycodone
Tramadol
Others
Segment by Application
Anesthesia
Pain relief
Cough suppression
Diarrhea suppression
Deaddiction
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Buprenorphine
1.2.3 Fentanyl
1.2.4 Hydrocodone
1.2.5 Morphine
1.2.6 Oxycodone
1.2.7 Tramadol
1.2.8 Others
1.3 Market by Application
1.3.1 Global Opioid Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Anesthesia
1.3.3 Pain relief
1.3.4 Cough suppression
1.3.5 Diarrhea suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid Drugs Market Perspective (2019-2030)
2.2 Opioid Drugs Growth Trends by Region
2.2.1 Global Opioid Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Opioid Drugs Historic Market Size by Region (2019-2024)
2.2.3 Opioid Drugs Forecasted Market Size by Region (2025-2030)
2.3 Opioid Drugs Market Dynamics
2.3.1 Opioid Drugs Industry Trends
2.3.2 Opioid Drugs Market Drivers
2.3.3 Opioid Drugs Market Challenges
2.3.4 Opioid Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Drugs Players by Revenue
3.1.1 Global Top Opioid Drugs Players by Revenue (2019-2024)
3.1.2 Global Opioid Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid Drugs Revenue
3.4 Global Opioid Drugs Market Concentration Ratio
3.4.1 Global Opioid Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Drugs Revenue in 2023
3.5 Opioid Drugs Key Players Head office and Area Served
3.6 Key Players Opioid Drugs Product Solution and Service
3.7 Date of Enter into Opioid Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Drugs Breakdown Data by Type
4.1 Global Opioid Drugs Historic Market Size by Type (2019-2024)
4.2 Global Opioid Drugs Forecasted Market Size by Type (2025-2030)
5 Opioid Drugs Breakdown Data by Application
5.1 Global Opioid Drugs Historic Market Size by Application (2019-2024)
5.2 Global Opioid Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Opioid Drugs Market Size (2019-2030)
6.2 North America Opioid Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Opioid Drugs Market Size by Country (2019-2024)
6.4 North America Opioid Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioid Drugs Market Size (2019-2030)
7.2 Europe Opioid Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Opioid Drugs Market Size by Country (2019-2024)
7.4 Europe Opioid Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioid Drugs Market Size (2019-2030)
8.2 Asia-Pacific Opioid Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Opioid Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Opioid Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioid Drugs Market Size (2019-2030)
9.2 Latin America Opioid Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Opioid Drugs Market Size by Country (2019-2024)
9.4 Latin America Opioid Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Drugs Market Size (2019-2030)
10.2 Middle East & Africa Opioid Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Opioid Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Opioid Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acura Pharmaceuticals
11.1.1 Acura Pharmaceuticals Company Detail
11.1.2 Acura Pharmaceuticals Business Overview
11.1.3 Acura Pharmaceuticals Opioid Drugs Introduction
11.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2019-2024)
11.1.5 Acura Pharmaceuticals Recent Development
11.2 Cipher Pharmaceutical Inc.
11.2.1 Cipher Pharmaceutical Inc. Company Detail
11.2.2 Cipher Pharmaceutical Inc. Business Overview
11.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction
11.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2019-2024)
11.2.5 Cipher Pharmaceutical Inc. Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Detail
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Opioid Drugs Introduction
11.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2019-2024)
11.3.5 Daiichi Sankyo Recent Development
11.4 Johnson&Johnson
11.4.1 Johnson&Johnson Company Detail
11.4.2 Johnson&Johnson Business Overview
11.4.3 Johnson&Johnson Opioid Drugs Introduction
11.4.4 Johnson&Johnson Revenue in Opioid Drugs Business (2019-2024)
11.4.5 Johnson&Johnson Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Detail
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Opioid Drugs Introduction
11.5.4 Lupin Limited Revenue in Opioid Drugs Business (2019-2024)
11.5.5 Lupin Limited Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Opioid Drugs Introduction
11.6.4 Pfizer Revenue in Opioid Drugs Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Company Detail
11.7.2 Sun Pharmaceuticals Business Overview
11.7.3 Sun Pharmaceuticals Opioid Drugs Introduction
11.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2019-2024)
11.7.5 Sun Pharmaceuticals Recent Development
11.8 Teva Pharmaceutical Industries Ltd.
11.8.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.8.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction
11.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2019-2024)
11.8.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Buprenorphine
1.2.3 Fentanyl
1.2.4 Hydrocodone
1.2.5 Morphine
1.2.6 Oxycodone
1.2.7 Tramadol
1.2.8 Others
1.3 Market by Application
1.3.1 Global Opioid Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Anesthesia
1.3.3 Pain relief
1.3.4 Cough suppression
1.3.5 Diarrhea suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid Drugs Market Perspective (2019-2030)
2.2 Opioid Drugs Growth Trends by Region
2.2.1 Global Opioid Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Opioid Drugs Historic Market Size by Region (2019-2024)
2.2.3 Opioid Drugs Forecasted Market Size by Region (2025-2030)
2.3 Opioid Drugs Market Dynamics
2.3.1 Opioid Drugs Industry Trends
2.3.2 Opioid Drugs Market Drivers
2.3.3 Opioid Drugs Market Challenges
2.3.4 Opioid Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Drugs Players by Revenue
3.1.1 Global Top Opioid Drugs Players by Revenue (2019-2024)
3.1.2 Global Opioid Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid Drugs Revenue
3.4 Global Opioid Drugs Market Concentration Ratio
3.4.1 Global Opioid Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Drugs Revenue in 2023
3.5 Opioid Drugs Key Players Head office and Area Served
3.6 Key Players Opioid Drugs Product Solution and Service
3.7 Date of Enter into Opioid Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Drugs Breakdown Data by Type
4.1 Global Opioid Drugs Historic Market Size by Type (2019-2024)
4.2 Global Opioid Drugs Forecasted Market Size by Type (2025-2030)
5 Opioid Drugs Breakdown Data by Application
5.1 Global Opioid Drugs Historic Market Size by Application (2019-2024)
5.2 Global Opioid Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Opioid Drugs Market Size (2019-2030)
6.2 North America Opioid Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Opioid Drugs Market Size by Country (2019-2024)
6.4 North America Opioid Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioid Drugs Market Size (2019-2030)
7.2 Europe Opioid Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Opioid Drugs Market Size by Country (2019-2024)
7.4 Europe Opioid Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioid Drugs Market Size (2019-2030)
8.2 Asia-Pacific Opioid Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Opioid Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Opioid Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioid Drugs Market Size (2019-2030)
9.2 Latin America Opioid Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Opioid Drugs Market Size by Country (2019-2024)
9.4 Latin America Opioid Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Drugs Market Size (2019-2030)
10.2 Middle East & Africa Opioid Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Opioid Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Opioid Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acura Pharmaceuticals
11.1.1 Acura Pharmaceuticals Company Detail
11.1.2 Acura Pharmaceuticals Business Overview
11.1.3 Acura Pharmaceuticals Opioid Drugs Introduction
11.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2019-2024)
11.1.5 Acura Pharmaceuticals Recent Development
11.2 Cipher Pharmaceutical Inc.
11.2.1 Cipher Pharmaceutical Inc. Company Detail
11.2.2 Cipher Pharmaceutical Inc. Business Overview
11.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction
11.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2019-2024)
11.2.5 Cipher Pharmaceutical Inc. Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Detail
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Opioid Drugs Introduction
11.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2019-2024)
11.3.5 Daiichi Sankyo Recent Development
11.4 Johnson&Johnson
11.4.1 Johnson&Johnson Company Detail
11.4.2 Johnson&Johnson Business Overview
11.4.3 Johnson&Johnson Opioid Drugs Introduction
11.4.4 Johnson&Johnson Revenue in Opioid Drugs Business (2019-2024)
11.4.5 Johnson&Johnson Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Detail
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Opioid Drugs Introduction
11.5.4 Lupin Limited Revenue in Opioid Drugs Business (2019-2024)
11.5.5 Lupin Limited Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Opioid Drugs Introduction
11.6.4 Pfizer Revenue in Opioid Drugs Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Company Detail
11.7.2 Sun Pharmaceuticals Business Overview
11.7.3 Sun Pharmaceuticals Opioid Drugs Introduction
11.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2019-2024)
11.7.5 Sun Pharmaceuticals Recent Development
11.8 Teva Pharmaceutical Industries Ltd.
11.8.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.8.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction
11.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2019-2024)
11.8.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Opioid Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Buprenorphine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Hydrocodone
Table 5. Key Players of Morphine
Table 6. Key Players of Oxycodone
Table 7. Key Players of Tramadol
Table 8. Key Players of Others
Table 9. Global Opioid Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Opioid Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Opioid Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Opioid Drugs Market Share by Region (2019-2024)
Table 13. Global Opioid Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Opioid Drugs Market Share by Region (2025-2030)
Table 15. Opioid Drugs Market Trends
Table 16. Opioid Drugs Market Drivers
Table 17. Opioid Drugs Market Challenges
Table 18. Opioid Drugs Market Restraints
Table 19. Global Opioid Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Opioid Drugs Market Share by Players (2019-2024)
Table 21. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2023)
Table 22. Ranking of Global Top Opioid Drugs Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Opioid Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Opioid Drugs Product Solution and Service
Table 26. Date of Enter into Opioid Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Opioid Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Opioid Drugs Revenue Market Share by Type (2019-2024)
Table 30. Global Opioid Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Opioid Drugs Revenue Market Share by Type (2025-2030)
Table 32. Global Opioid Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Opioid Drugs Revenue Market Share by Application (2019-2024)
Table 34. Global Opioid Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Opioid Drugs Revenue Market Share by Application (2025-2030)
Table 36. North America Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Opioid Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Opioid Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Opioid Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Opioid Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Opioid Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Opioid Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Opioid Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Opioid Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Opioid Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Opioid Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Opioid Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 51. Acura Pharmaceuticals Company Detail
Table 52. Acura Pharmaceuticals Business Overview
Table 53. Acura Pharmaceuticals Opioid Drugs Product
Table 54. Acura Pharmaceuticals Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 55. Acura Pharmaceuticals Recent Development
Table 56. Cipher Pharmaceutical Inc. Company Detail
Table 57. Cipher Pharmaceutical Inc. Business Overview
Table 58. Cipher Pharmaceutical Inc. Opioid Drugs Product
Table 59. Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 60. Cipher Pharmaceutical Inc. Recent Development
Table 61. Daiichi Sankyo Company Detail
Table 62. Daiichi Sankyo Business Overview
Table 63. Daiichi Sankyo Opioid Drugs Product
Table 64. Daiichi Sankyo Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 65. Daiichi Sankyo Recent Development
Table 66. Johnson&Johnson Company Detail
Table 67. Johnson&Johnson Business Overview
Table 68. Johnson&Johnson Opioid Drugs Product
Table 69. Johnson&Johnson Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 70. Johnson&Johnson Recent Development
Table 71. Lupin Limited Company Detail
Table 72. Lupin Limited Business Overview
Table 73. Lupin Limited Opioid Drugs Product
Table 74. Lupin Limited Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 75. Lupin Limited Recent Development
Table 76. Pfizer Company Detail
Table 77. Pfizer Business Overview
Table 78. Pfizer Opioid Drugs Product
Table 79. Pfizer Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Sun Pharmaceuticals Company Detail
Table 82. Sun Pharmaceuticals Business Overview
Table 83. Sun Pharmaceuticals Opioid Drugs Product
Table 84. Sun Pharmaceuticals Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 85. Sun Pharmaceuticals Recent Development
Table 86. Teva Pharmaceutical Industries Ltd. Company Detail
Table 87. Teva Pharmaceutical Industries Ltd. Business Overview
Table 88. Teva Pharmaceutical Industries Ltd. Opioid Drugs Product
Table 89. Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 90. Teva Pharmaceutical Industries Ltd. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Opioid Drugs Market Share by Type: 2023 VS 2030
Figure 3. Buprenorphine Features
Figure 4. Fentanyl Features
Figure 5. Hydrocodone Features
Figure 6. Morphine Features
Figure 7. Oxycodone Features
Figure 8. Tramadol Features
Figure 9. Others Features
Figure 10. Global Opioid Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Opioid Drugs Market Share by Application: 2023 VS 2030
Figure 12. Anesthesia Case Studies
Figure 13. Pain relief Case Studies
Figure 14. Cough suppression Case Studies
Figure 15. Diarrhea suppression Case Studies
Figure 16. Deaddiction Case Studies
Figure 17. Others Case Studies
Figure 18. Opioid Drugs Report Years Considered
Figure 19. Global Opioid Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 20. Global Opioid Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Opioid Drugs Market Share by Region: 2023 VS 2030
Figure 22. Global Opioid Drugs Market Share by Players in 2023
Figure 23. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2023)
Figure 24. The Top 10 and 5 Players Market Share by Opioid Drugs Revenue in 2023
Figure 25. North America Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. North America Opioid Drugs Market Share by Country (2019-2030)
Figure 27. United States Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Opioid Drugs Market Share by Country (2019-2030)
Figure 31. Germany Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Opioid Drugs Market Share by Region (2019-2030)
Figure 39. China Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Japan Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Latin America Opioid Drugs Market Share by Country (2019-2030)
Figure 47. Mexico Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Brazil Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Opioid Drugs Market Share by Country (2019-2030)
Figure 51. Turkey Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Acura Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 54. Cipher Pharmaceutical Inc. Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 55. Daiichi Sankyo Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 56. Johnson&Johnson Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 57. Lupin Limited Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 59. Sun Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 60. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Opioid Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Buprenorphine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Hydrocodone
Table 5. Key Players of Morphine
Table 6. Key Players of Oxycodone
Table 7. Key Players of Tramadol
Table 8. Key Players of Others
Table 9. Global Opioid Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Opioid Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Opioid Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Opioid Drugs Market Share by Region (2019-2024)
Table 13. Global Opioid Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Opioid Drugs Market Share by Region (2025-2030)
Table 15. Opioid Drugs Market Trends
Table 16. Opioid Drugs Market Drivers
Table 17. Opioid Drugs Market Challenges
Table 18. Opioid Drugs Market Restraints
Table 19. Global Opioid Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Opioid Drugs Market Share by Players (2019-2024)
Table 21. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2023)
Table 22. Ranking of Global Top Opioid Drugs Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Opioid Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Opioid Drugs Product Solution and Service
Table 26. Date of Enter into Opioid Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Opioid Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Opioid Drugs Revenue Market Share by Type (2019-2024)
Table 30. Global Opioid Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Opioid Drugs Revenue Market Share by Type (2025-2030)
Table 32. Global Opioid Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Opioid Drugs Revenue Market Share by Application (2019-2024)
Table 34. Global Opioid Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Opioid Drugs Revenue Market Share by Application (2025-2030)
Table 36. North America Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Opioid Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Opioid Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Opioid Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Opioid Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Opioid Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Opioid Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Opioid Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Opioid Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Opioid Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Opioid Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Opioid Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 51. Acura Pharmaceuticals Company Detail
Table 52. Acura Pharmaceuticals Business Overview
Table 53. Acura Pharmaceuticals Opioid Drugs Product
Table 54. Acura Pharmaceuticals Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 55. Acura Pharmaceuticals Recent Development
Table 56. Cipher Pharmaceutical Inc. Company Detail
Table 57. Cipher Pharmaceutical Inc. Business Overview
Table 58. Cipher Pharmaceutical Inc. Opioid Drugs Product
Table 59. Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 60. Cipher Pharmaceutical Inc. Recent Development
Table 61. Daiichi Sankyo Company Detail
Table 62. Daiichi Sankyo Business Overview
Table 63. Daiichi Sankyo Opioid Drugs Product
Table 64. Daiichi Sankyo Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 65. Daiichi Sankyo Recent Development
Table 66. Johnson&Johnson Company Detail
Table 67. Johnson&Johnson Business Overview
Table 68. Johnson&Johnson Opioid Drugs Product
Table 69. Johnson&Johnson Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 70. Johnson&Johnson Recent Development
Table 71. Lupin Limited Company Detail
Table 72. Lupin Limited Business Overview
Table 73. Lupin Limited Opioid Drugs Product
Table 74. Lupin Limited Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 75. Lupin Limited Recent Development
Table 76. Pfizer Company Detail
Table 77. Pfizer Business Overview
Table 78. Pfizer Opioid Drugs Product
Table 79. Pfizer Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Sun Pharmaceuticals Company Detail
Table 82. Sun Pharmaceuticals Business Overview
Table 83. Sun Pharmaceuticals Opioid Drugs Product
Table 84. Sun Pharmaceuticals Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 85. Sun Pharmaceuticals Recent Development
Table 86. Teva Pharmaceutical Industries Ltd. Company Detail
Table 87. Teva Pharmaceutical Industries Ltd. Business Overview
Table 88. Teva Pharmaceutical Industries Ltd. Opioid Drugs Product
Table 89. Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2019-2024) & (US$ Million)
Table 90. Teva Pharmaceutical Industries Ltd. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Opioid Drugs Market Share by Type: 2023 VS 2030
Figure 3. Buprenorphine Features
Figure 4. Fentanyl Features
Figure 5. Hydrocodone Features
Figure 6. Morphine Features
Figure 7. Oxycodone Features
Figure 8. Tramadol Features
Figure 9. Others Features
Figure 10. Global Opioid Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Opioid Drugs Market Share by Application: 2023 VS 2030
Figure 12. Anesthesia Case Studies
Figure 13. Pain relief Case Studies
Figure 14. Cough suppression Case Studies
Figure 15. Diarrhea suppression Case Studies
Figure 16. Deaddiction Case Studies
Figure 17. Others Case Studies
Figure 18. Opioid Drugs Report Years Considered
Figure 19. Global Opioid Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 20. Global Opioid Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Opioid Drugs Market Share by Region: 2023 VS 2030
Figure 22. Global Opioid Drugs Market Share by Players in 2023
Figure 23. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2023)
Figure 24. The Top 10 and 5 Players Market Share by Opioid Drugs Revenue in 2023
Figure 25. North America Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. North America Opioid Drugs Market Share by Country (2019-2030)
Figure 27. United States Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Opioid Drugs Market Share by Country (2019-2030)
Figure 31. Germany Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Opioid Drugs Market Share by Region (2019-2030)
Figure 39. China Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Japan Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Latin America Opioid Drugs Market Share by Country (2019-2030)
Figure 47. Mexico Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Brazil Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Opioid Drugs Market Share by Country (2019-2030)
Figure 51. Turkey Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Opioid Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Acura Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 54. Cipher Pharmaceutical Inc. Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 55. Daiichi Sankyo Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 56. Johnson&Johnson Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 57. Lupin Limited Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 59. Sun Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 60. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Opioid Drugs Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232